Company patents
Evalve, Inc.
EVALVE, INC's patent strategy reveals a strong, sustained focus on core medical device areas, with Implants & Prosthetics representing 77.8% of its portfolio and Medical Diagnostics & Surgery at 66.7%. While both categories saw significant growth in 2024 (Implants & Prosthetics +115.4%, Medical Diagnostics & Surgery +61.5%), the rapid 33.3% year-over-year growth in Drug Delivery Devices so far in 2026, following a sharp decline in 2025, suggests an emerging focus on this area despite its smaller 18.2% share of the overall portfolio.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
99 US filings (since 2023) · 3 categories · 6 themes
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Implantable devices designed to manage or redirect bodily fluids, including stents for ducts, and systems for draining or accumulating fluids within internal cavities.
Patents
Showing 1-10 of 151